Revvity (NYSE:RVTY) Issues FY 2026 Earnings Guidance

Revvity (NYSE:RVTY) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 5.300-5.400 for the period, compared to the consensus estimate of 5.250. The company issued revenue guidance of $2.8 billion-$2.9 billion, compared to the consensus revenue estimate of $2.8 billion.

Revvity Trading Down 3.8%

Revvity stock traded down $4.38 during mid-day trading on Tuesday, hitting $110.84. The company’s stock had a trading volume of 837,698 shares, compared to its average volume of 1,376,879. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72. The company has a 50 day moving average of $106.88 and a 200-day moving average of $99.92. Revvity has a one year low of $81.22 and a one year high of $118.30. The stock has a market cap of $12.37 billion, a PE ratio of 53.12, a P/E/G ratio of 2.21 and a beta of 1.07.

Revvity (NYSE:RVTY) last released its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.20. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The business’s quarterly revenue was down 1.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, research analysts anticipate that Revvity will post 5.25 EPS for the current year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity’s dividend payout ratio (DPR) is presently 13.40%.

Analyst Ratings Changes

RVTY has been the topic of a number of research analyst reports. Wall Street Zen downgraded shares of Revvity from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. TD Cowen reiterated a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Wolfe Research assumed coverage on Revvity in a research note on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Sanford C. Bernstein began coverage on Revvity in a report on Friday, June 26th. They set a “market perform” rating and a $115.00 price objective on the stock. Finally, Stifel Nicolaus decreased their target price on Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research report on Wednesday, May 6th. Three equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $108.36.

Institutional Investors Weigh In On Revvity

Large investors have recently modified their holdings of the business. AQR Capital Management LLC increased its holdings in Revvity by 5.2% during the first quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock valued at $883,000 after buying an additional 420 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Revvity by 6.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock worth $1,246,000 after buying an additional 744 shares during the period. Millennium Management LLC lifted its holdings in Revvity by 102.0% during the first quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock worth $7,343,000 after buying an additional 35,048 shares during the period. Goldman Sachs Group Inc. boosted its position in Revvity by 45.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock valued at $64,232,000 after acquiring an additional 189,871 shares in the last quarter. Finally, Focus Partners Wealth boosted its position in Revvity by 13.0% during the 1st quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock valued at $744,000 after acquiring an additional 811 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.